Recently, Mitchell et al. have demonstrated that antitumor activity associated with DC vaccinations can be increased by administering TT as a preconditioning step.18 As virtually all people have been vaccinated against tetanus, the recall antigen can attract locally CD4+ T cells that release the CCL3 chemokine, upregulating the expression of CCL21. Here, CCL21 is linked to tetanus.